A Randomized Open Label Phase-II Control Trial to Evaluate the Efficacy and Safety of Silodosin in the Treatment of Lower Urinary Tract Symptoms in Taiwanese Population.
Status: Unknown
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
To evaluate the therapeutic effects and safety of silodosin in the patients of acute brain injury with lower urinary tract symptoms.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 100
Healthy Volunteers: f
View:
• Subject ≥ 20 years of age
• Newly diagnosed of acute brain injury with Foley insertion with 5 days
Locations
Other Locations
Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital
RECRUITING
Kaohsiung City
Contact Information
Primary
Chen Yu Chen, MS
jennis7995@hotmail.com
0911884597
Time Frame
Start Date: 2022-02-18
Completion Date: 2024-12-31
Participants
Target number of participants: 70
Treatments
Experiment group
1. Subject ≥ 20 years of age~2. Newly diagnosed of acute brain injury with Foley insertion with 5 days
Related Therapeutic Areas
Sponsors
Leads: Kaohsiung Medical University Chung-Ho Memorial Hospital